Kaival Labs

Kaival Labs is a specialized subsidiary of Kaival Brands Innovations Group, dedicated to the research, development, and licensing of proprietary aerosol and inhalation delivery technologies. The company focuses on transforming its patented intellectual property into pharmaceutical-grade delivery systems for a variety of active ingredients, including nicotine and cannabinoids. By optimizing the bioavailability and delivery speed of these compounds, Kaival Labs aims to address unmet needs in smoking cessation and other therapeutic areas. The entity serves as the innovation hub for the parent company, managing a portfolio of over 60 patents and patents-pending. Its work is central to the group's strategy of expanding beyond the consumer vaping market into regulated healthcare sectors.